Mitsutaka Okuda
Mitsutaka Okuda publishes mostly in Hematology, Immunology and Genetics, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Retinoids in leukemia and cellular processes.
- World rank
- #6,736,333 of 7,710,434 ranked researchers
- Rank in Japan
- #283,028 of 383,136
- Works
- 18
- Citations
- 179
- Citations per work
- 9.9
What does Mitsutaka Okuda research?
Mitsutaka Okuda's work is mostly in Medicine (51%), Immunology and Microbiology (11%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences951.1%
- Medicine951.1%
- Everything else529.8%
- Life Sciences319.1%
- 1Hematology32% of their works
- 2Immunology11% of their works
- 3Genetics8% of their works
- 4Molecular Biology8% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Retinoids in leukemia and cellular processes
- Immune Cell Function and Interaction
- Hematopoietic Stem Cell Transplantation
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
Which keywords describe Mitsutaka Okuda's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib, Acute Promyelocytic Leukemia and Bone Marrow Niche.
- Myelofibrosis
- Childhood Cancer
- Retinoic Acid
- NK Cell Recognition
- Graft-versus-Host Disease
- Bone Marrow Niche
- Imatinib
- Acute Myeloid Leukemia
- Prognostic Factors
- Hematopoietic Stem Cells
- AML
- BCR-ABL
- Acute Promyelocytic Leukemia
- Classification
- Lymphoma
- Natural Killer Cells
- Acute Lymphoblastic Leukemia
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Hematopoietic Stem Cells102 topics
- Prognostic Factors92 topics
- AML71 topic
- Acute Myeloid Leukemia71 topic
- BCR-ABL41 topic
- Imatinib41 topic
- Acute Promyelocytic Leukemia31 topic
- Bone Marrow Niche31 topic
- Classification31 topic
- Graft-versus-Host Disease31 topic
- Lymphoma31 topic
- NK Cell Recognition31 topic
- Natural Killer Cells31 topic
- Retinoic Acid31 topic
- Acute Lymphoblastic Leukemia21 topic
- Childhood Cancer21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
Where does Mitsutaka Okuda work?
Mitsutaka Okuda's main affiliation in the publication record is Tohoku University, Japan.
How many publications and citations does Mitsutaka Okuda have?
OpenAlex counts 18 works and 179 citations for Mitsutaka Okuda, an h-index of 7, ranking #6,736,333 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mitsutaka Okuda. Posts are plain text and can be reported.